Zymewire Blog

Exploring the frontiers of biotech & pharma.

Join us as we dive into the sea of emerging biotechs, discuss industry news and the implications they have on providers to biopharma (CROs, CDMOs, eClinical, etc.), and tips for prospecting within the everchanging world of life sciences. 

OUR LATEST

Zymewire Blog

Q1 Biopharma Recap

22 Apr, 2024
Read More
Rectangle 10

Subscribe Now
Rectangle 10

Recent Posts

Why Your Cold Outreach to Biotechs (Still) isn't Working: A Battle with AI
Why Your Cold Outreach to Biotechs (Still) isn't Working: A Battle with AI
06 Mar, 2024
Industry Articles
by Alec de la Durantaye

Goals & Hurdles

Read More
2023 Biopharma Funding Recap: Beyond the Surface
2023 Biopharma Funding Recap: Beyond the Surface
24 Jan, 2024
Industry Articles
by Alec de la Durantaye

Review of 2023 Biopharma Funding: How can sales and business development teams at service providers adapt for 2024?

Read More
Preparing for CPhI: Drug Sponsor Overview
Preparing for CPhI: Drug Sponsor Overview
12 Oct, 2023
Industry Articles
by Alec de la Durantaye

Road to Barcelona

Read More
The IRA Effect: How the Inflation Reduction Act Will Reshape Behaviors in Biopharma
The IRA Effect: How the Inflation Reduction Act Will Reshape Behaviors in Biopharma
15 Sep, 2023
Industry Articles
by Alec de la Durantaye

The IRA: What is it? Signed into law in August 2022, the Inflation Reduction Act (IRA) was designed to fight inflation, invest in domestic ...

Read More
Inside BIO 2023: Uncovering the Biopharma Landscape
Inside BIO 2023: Uncovering the Biopharma Landscape
30 May, 2023
Industry Articles
by Alec de la Durantaye

Countdown to Boston

Read More
Navigating the Aftermath: What Lies Ahead for Biopharma Following the Collapse of SVB
Navigating the Aftermath: What Lies Ahead for Biopharma Following the Collapse of SVB
30 Mar, 2023
Industry Articles
by Alec de la Durantaye

Crisis Averted?

Read More
What’s the deal with NLP?
What’s the deal with NLP?
03 Dec, 2021
Industry Articles
by Ian Hamilton-Burge, Director of Customer Solutions

Machine learning. Artificial intelligence. Predictive analytics.

Read More
How the Heck to Find Your Way Around the Cell and Gene Therapy Space
How the Heck to Find Your Way Around the Cell and Gene Therapy Space
15 Oct, 2021
Industry Articles
by Team Zymewire

We know that the cell and gene therapy space is unique – and can be uniquely challenging to navigate, with specific quirks and nuances.

Read More
The Latest on Return to Business Travel
The Latest on Return to Business Travel
27 Sep, 2021
Industry Articles
by Team Zymewire

We had all hoped for far more certainty around travel this coming fall – but as the delta variant continues to wreak havoc around the ...

Read More
Remote Buying in a Virtual World: 6 Reflections from a Pharma Procurement Exec.
Remote Buying in a Virtual World: 6 Reflections from a Pharma Procurement Exec.
27 Aug, 2021
Industry Articles
by Team Zymewire

Recently, Zymewire’s Scott Ballenger had an opportunity to sit down with Stefanie Kuhner, an executive in the procurement department from ...

Read More
11 Insights to Help Build Great Partnerships with Cell & Gene Therapy Companies
11 Insights to Help Build Great Partnerships with Cell & Gene Therapy Companies
16 Jun, 2021
Industry Articles
by Ian Hamilton-Burge, Director of Customer Solutions

During our ongoing conversations with clients here at Zymewire, it became clear that cell and gene therapy companies were really heating up ...

Read More
Discovering Stealth Companies: Neuway Pharma from Bonn, Germany
Discovering Stealth Companies: Neuway Pharma from Bonn, Germany
16 Jun, 2021
Industry Articles
by Sara El-Talmas, Zymewire

We’re looking at Neuway Pharma, a Europe-based biotech startup, in this edition of Sponsor Atlas series. This branch of the blog focuses on ...

Read More
Discovering Biotech Startups: A map for Selling to Vanguard Therapeutics
Discovering Biotech Startups: A map for Selling to Vanguard Therapeutics
08 Dec, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Canget BioTekpharma: A One Pager for Selling to this Stealth Biotech Startup
Canget BioTekpharma: A One Pager for Selling to this Stealth Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Braizon Therapeutics: A Map for Selling to this Japanese Stealth Biotech Startup
Braizon Therapeutics: A Map for Selling to this Japanese Stealth Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

In this edition of Sponsor Atlas: Discovering Biotech Startups, we’re looking at Braizon Therapeutics (Braizon). We will give a business ...

Read More
Mekanistic Therapeutics: A Map for Selling to this Stealth Biotech Startup
Mekanistic Therapeutics: A Map for Selling to this Stealth Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Sulfateq BV: A Map for Selling to this European Biotech Startup
Sulfateq BV: A Map for Selling to this European Biotech Startup
08 Dec, 2020
Industry Articles
by Amarpreet Singh

In this edition of Sponsor Atlas: Discovering Biotech Startups, we are looking at Sulfateq BV (Sulfateq), exploring the current affairs and ...

Read More
Montisera: A Map for selling to this emerging European Biotech
Montisera: A Map for selling to this emerging European Biotech
08 Dec, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Tiburio Therapeutics: A Map for Selling to this Stealth Biotech Startup
Tiburio Therapeutics: A Map for Selling to this Stealth Biotech Startup
21 Oct, 2020
Industry Articles
by Amarpreet Singh

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
All About AbbVie: A map for Selling to AbbVie
All About AbbVie: A map for Selling to AbbVie
30 Sep, 2020
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Discovering Biotech Startups: A map for Selling to Geneos Therapeutics
Discovering Biotech Startups: A map for Selling to Geneos Therapeutics
16 Sep, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Blueprint to Biogen: A map for Selling to Biogen
Blueprint to Biogen: A map for Selling to Biogen
08 Sep, 2020
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Discovering Biotech Startups: A map for Selling to Pyxis Oncology
Discovering Biotech Startups: A map for Selling to Pyxis Oncology
01 Sep, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Felix Biotechnology
Discovering Biotech Startups: A map for Selling to Felix Biotechnology
01 Sep, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Sales Intelligence Products: Things to Consider for Your Team
Sales Intelligence Products: Things to Consider for Your Team
31 Aug, 2020
Industry Articles
by Sean Cannon

In today’s world, many providers are claiming to be sales intelligence solutions. This statement is remarkably convoluted, as the category ...

Read More
Twentyeight-Seven Therapeutics: A One Pager for Selling to this Stealth Biotech Startup
Twentyeight-Seven Therapeutics: A One Pager for Selling to this Stealth Biotech Startup
17 Aug, 2020
Industry Articles
by Amarpreet Singh

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A Map for Selling to NanoCell Therapeutics
Discovering Biotech Startups: A Map for Selling to NanoCell Therapeutics
23 Jun, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Symbiotica
Discovering Biotech Startups: A map for Selling to Symbiotica
23 Jun, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Snap Bio
Discovering Biotech Startups: A map for Selling to Snap Bio
03 Jun, 2020
Industry Articles
by David Wilkerson

This branch of our Sponsor Atlas series focuses on young pharmaceutical and biotechnology companies that are in early stages or stealth ...

Read More
Discovering Biotech Startups: A map for Selling to Intrepida Bio
Discovering Biotech Startups: A map for Selling to Intrepida Bio
03 Jun, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Alaya Bioscience
Discovering Biotech Startups: A map for Selling to Alaya Bioscience
03 Apr, 2020
Industry Articles
by David Wilkerson

We are moving right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology ...

Read More
Discovering Biotech Startups: A map for Selling to Avenzoar Pharmaceuticals
Discovering Biotech Startups: A map for Selling to Avenzoar Pharmaceuticals
03 Apr, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Guide to Gilead: A map for Selling to Gilead Sciences
Guide to Gilead: A map for Selling to Gilead Sciences
01 Apr, 2020
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Decisions, Decisions: A map for Selling to Novartis
Decisions, Decisions: A map for Selling to Novartis
13 Mar, 2020
Industry Articles
by Xhermi Trimi

As a large, complex, multinational company, it isn’t all that obvious which decisions are made at which Novartis sites around the world. ...

Read More
Discovering Biotech Startups: A map for Selling to Soteria Biotherapeutics
Discovering Biotech Startups: A map for Selling to Soteria Biotherapeutics
11 Mar, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb
Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb
04 Mar, 2020
Industry Articles
by Xhermi Trimi

In this edition of Sponsor Atlas: Selling to the Pharma Giants, we're visiting New York City's biopharma behemoth, Bristol-Myers Squibb ...

Read More
Outsourcing in Pharma & Biotech: Shifting to Contract Manufacturing and Development
Outsourcing in Pharma & Biotech: Shifting to Contract Manufacturing and Development
04 Mar, 2020
Industry Articles
by David Wilkerson

As the world’s population ages and healthcare standards continue to rise, the demand for pharmaceutical products has been steadily ...

Read More
Discovering Biotech Startups: A map for Selling to Nitrome Biosciences
Discovering Biotech Startups: A map for Selling to Nitrome Biosciences
04 Mar, 2020
Industry Articles
by David Wilkerson

Welcome to the next edition of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies that are in ...

Read More
Activating Amgen: A map for Selling to Amgen
Activating Amgen: A map for Selling to Amgen
02 Mar, 2020
Industry Articles
by Xhermi Trimi

Amgen Inc. is one of the world’s 10 largest biopharmaceutical companies, founded and headquartered in California, USA. In 2018, Amgen ...

Read More
Finding Pfizer: A map for Selling to Pfizer
Finding Pfizer: A map for Selling to Pfizer
02 Mar, 2020
Industry Articles
by Xhermi Trimi

Pfizer Inc. is a global biopharmaceutical corporation headquartered in New York City, where it was founded in 1849. In 2019, they ranked #1 ...

Read More
Accessing Allergan: A map for Selling to Allergan
Accessing Allergan: A map for Selling to Allergan
24 Feb, 2020
Industry Articles
by Xhermi Trimi

Note: This article was originally written for 2019 publication, and has since been updated.

Read More
Mapping Merck: A map for Selling to Merck & Co.
Mapping Merck: A map for Selling to Merck & Co.
18 Feb, 2020
Industry Articles
by Xhermi Trimi

Merck & Co. is an American pharmaceutical company, ranked 4th internationally in the world in terms of 2017 prescription sales [1]. It ...

Read More
Discovering Biotech Startups: A map for Selling to Mitokinin
Discovering Biotech Startups: A map for Selling to Mitokinin
04 Feb, 2020
Industry Articles
by David Wilkerson

In the next edition of Sponsor Atlas: Discovering Biotech Startups, we’re looking at Mitokinin, exploring the current affairs and future ...

Read More
Discovering Biotech Startups: A map for Selling to Amagma Therapeutics
Discovering Biotech Startups: A map for Selling to Amagma Therapeutics
20 Jan, 2020
Industry Articles
by David Wilkerson

We are moving right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology ...

Read More
Discovering Biotech Startups: A map for Selling to Delve Therapeutics
Discovering Biotech Startups: A map for Selling to Delve Therapeutics
16 Jan, 2020
Industry Articles
by David Wilkerson

Welcome to the next edition of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies that are in ...

Read More
Discovering Biotech Startups: A map for Selling to Fountain Therapeutics
Discovering Biotech Startups: A map for Selling to Fountain Therapeutics
09 Jan, 2020
Industry Articles
by David Wilkerson

We are going right along with the new branch of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies ...

Read More
Discovering Biotech Startups: A map for Selling to Apricity Therapeutics
Discovering Biotech Startups: A map for Selling to Apricity Therapeutics
08 Jan, 2020
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to Cypre Inc.
Discovering Biotech Startups: A map for Selling to Cypre Inc.
17 Dec, 2019
Industry Articles
by David Wilkerson

Welcome to another edition of our Sponsor Atlas series, which focuses on startups and young pharmaceutical and biotechnology companies that ...

Read More
Discovering Biotech Startups: A map for Selling to CiberMed Inc.
Discovering Biotech Startups: A map for Selling to CiberMed Inc.
06 Dec, 2019
Industry Articles
by David Wilkerson

Welcome to the next edition of the Sponsor Atlas series, which focuses on young pharmaceutical and biotechnology companies that are in ...

Read More

Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads. Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.

Demo Zymewire
zymewire-inverted

©2024 Zymewire Logo Trademark of Zymewire, a Division of Lumerate Inc. All rights reserved. Salesforce, Sales Cloud, and others are trademarks of salesforce.com, Inc. and are used here with permission.